What's New
New Survey on the use of darolutamide in the treatment of metastatic castration-sensitive prostate cancer
The Canadian Cancer Society is conducting a survey on the advantages and disadvantages of the drug darolutamide for treating metastatic castration-sensitive prostate cancer. Patients and caregivers do not have to have experience with the drug to complete the survey, as information on their satisfaction with current treatments is valuable on its own. Survey participants also may have an opportunity to give testimonials or be interviewed about their experience with darolutamide or their current treatments. Results of the survey could lead to recommendations for darolutamide to be covered in Canada on public drug plans for people with this subset of prostate cancer. For information on participating in this survey, continue below.
You’re Invited to Participate!
The University of Ottawa Psychosocial Oncology Laboratory is conducting two important cancer-related studies. Dr. Sophie Lebel and her doctoral students are seeking volunteers for their research in these two areas:
Managing your fear of cancer recurrence: A research study for Canadian family caregivers
See related recruitment poster for details - Fear of Cancer Recurrence_Recruitment Flyer (.pdf)
Please note: This study requires women volunteers aged 18+ supporting an adult loved one who has been treated for cancer but has not experienced cancer recurrence.
Why am I Still Tired? A Group for Cancer-Related Fatigue
See related recruitment poster for details - Cancer Related Fatigue Group Study Flyer (.pdf)
These two research projects consist of weekly online group meetings over the course of seven and four weeks, respectively, and participation is on a first-come, first-served basis. Please consider participating – you could make a positive difference for the treatment of these commonly experienced conditions.
Friday, August 19, 2022 – Annual PCSO Barbeque, 4pm
Location: Ottawa Regional Cancer Foundation Maplesoft-Jones Facility
Thursday, July 14, 2022 – Zoom Meeting, 7pm
Sharing Session with a special focus on attendees with Advanced Prostate Cancer
Thursday, April 21, 2022 - Zoom meeting, 7pm
Justin Lorentz, M.Sc., Genetic Counselling.
Justin practices clinically out of the Sunnybrook Odette Cancer Centre in their Cancer Genetics and High Risk Program. He will bring us up to date on genetics as it relates to Prostate Cancer.
Register in advance for this meeting:
https://us06web.zoom.us/meeting/register/tZwsceirqz8rH9DaVZdeqMBQdWIL9_PVWu53
After registering, you will receive a confirmation email containing information about joining the meeting.
Year-end 2021
The Walnut is the official newsletter for PCS Ottawa, currently published approximately four times a year.
We thank you for your continued support!
